Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $48.3 million.

  • Veracyte's Cash from Investing Activities rose 225267.62% to $48.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$57.9 million, marking a year-over-year decrease of 115070.18%. This contributed to the annual value of -$56.3 million for FY2024, which is 47238.62% down from last year.
  • Latest data reveals that Veracyte reported Cash from Investing Activities of $48.3 million as of Q3 2025, which was up 225267.62% from -$224000.0 recorded in Q2 2025.
  • In the past 5 years, Veracyte's Cash from Investing Activities ranged from a high of $48.3 million in Q3 2025 and a low of -$575.6 million during Q1 2021
  • Moreover, its 5-year median value for Cash from Investing Activities was -$2.5 million (2023), whereas its average is -$42.8 million.
  • In the last 5 years, Veracyte's Cash from Investing Activities plummeted by 8645744.36% in 2021 and then surged by 225267.62% in 2025.
  • Over the past 5 years, Veracyte's Cash from Investing Activities (Quarter) stood at $385000.0 in 2021, then crashed by 6965.97% to -$26.4 million in 2022, then skyrocketed by 90.55% to -$2.5 million in 2023, then tumbled by 2068.24% to -$54.1 million in 2024, then surged by 189.14% to $48.3 million in 2025.
  • Its Cash from Investing Activities stands at $48.3 million for Q3 2025, versus -$224000.0 for Q2 2025 and -$51.8 million for Q1 2025.